Preservation of β-Cells as a Therapeutic Strategy for Diabetes
J Taneera, MM Saber-Ayad - Hormone and Metabolic …, 2024 - thieme-connect.com
The preservation of pancreatic islet β-cells is crucial in diabetes mellitus, encompassing
both type 1 and type 2 diabetes. β-cell dysfunction, reduced mass, and apoptosis are central …
both type 1 and type 2 diabetes. β-cell dysfunction, reduced mass, and apoptosis are central …
The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review
O Alshahrani, MS Almalki - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Obesity is a global public health challenge that poses a significant threat to the effective
control and management of type 2 diabetes mellitus (T2DM). Being overweight/obese with …
control and management of type 2 diabetes mellitus (T2DM). Being overweight/obese with …
Efficacy of montelukast as an adjuvant therapy in rheumatoid arthritis patients: A randomized controlled study
Objective This study aimed to evaluate the efficacy of montelukast in conjunction with non-
biologic disease modifying anti-rheumatic drugs (nDMARDs) in rheumatoid arthritis (RA) …
biologic disease modifying anti-rheumatic drugs (nDMARDs) in rheumatoid arthritis (RA) …
Anti-enzymatic and DNA docking studies of montelukast: A multifaceted molecular scaffold with in vitro investigations, molecular expression analysis and molecular …
Montelukast, an approved leukotriene receptor 1 (Cys-LT 1) antagonist with anti-
inflammatory properties is used for the treatment of asthma and allergic rhinitis. In the …
inflammatory properties is used for the treatment of asthma and allergic rhinitis. In the …